Scancell Holdings plc (LON:SCLP) Insider Martin Diggle Acquires 44,944 Shares

Scancell Holdings plc (LON:SCLP) insider Martin Diggle purchased 44,944 shares of Scancell stock in a transaction that occurred on Tuesday, May 20th. The shares were bought at an average price of GBX 9 ($0.12) per share, with a total value of £4,044.96 ($5,424.38).

Scancell Price Performance

LON SCLP opened at GBX 9.90 ($0.13) on Thursday. The company has a market cap of £102.54 million, a PE ratio of -15.18 and a beta of 0.35. Scancell Holdings plc has a 52 week low of GBX 7.26 ($0.10) and a 52 week high of GBX 19.75 ($0.26). The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of -566.79. The firm’s 50-day simple moving average is GBX 9.35 and its two-hundred day simple moving average is GBX 10.24.

Scancell Company Profile

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.